Product Code: 4949
Title:
Cardiovascular Devices Market Size By Device Type (Cardiac Ablation Devices {Radiofrequency Ablators, Electric Ablators, Cryoablation Devices, Ultrasound Devices}, Left Atrial Appendage (LAA) Closure Devices {Endocardial LAA Closure Devices, Epicardial LAA Closure Devices}, Endoscopic Vessel Harvesting (EVH) Devices {EVH Systems, Endoscopes, Accessories}), By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027.
The cardiovascular devices market is set to record significant gains over the forthcoming timeframe due to growing geriatric population, rising incidences of cardiac diseases, increasingly sedentary lifestyles, and escalating adoption of radiofrequency ablators devices. A cardiac device is a device which is used for keeping the heart beating with a normal rhythm.
As per the Centers for Disease Control and Prevention, heart disease is one of the major causes of death among men and women across the U.S. In fact, it causes one in every four deaths, amounting to around 610,000 people each year.
With the increasing prevalence of cardiovascular diseases caused by lifestyle risk factors, cardiovascular devices and monitoring devices are experiencing more demand. Cardiovascular medical devices like angioplasty balloon catheters, coronary stents, artificial heart valves, and endovascular grafts save innumerable lives every year and can dramatically enhance the quality of life of hundreds of millions of people.
The cardiovascular devices market is bifurcated into many segments in terms of product, end-use, and regional landscape.
With respect to product, the market for cardiovascular devices is classified into endoscopic vessel harvesting devices, left atrial appendage closure devices, and cardiac ablation devices. Cardiac ablation is known as a minimally invasive treatment and can also effectively treat many arrhythmias, effectively preventing critical complications like sudden cardiac arrest. These types of devices are further categorized into ultrasound devices, cryoablation devices, electric ablators, radiofrequency ablators, and others.
Among these, the radiofrequency ablators segment held the largest market share of cardiac ablation devices in 2020 and is expected to see tremendous growth over the coming years. High efficiency in treatment of atrial fibrillation and growing development of RF ablators by organizations is also strengthening the industry outlook.
Radiofrequency ablation aids in restoring the normal heartbeat, mainly by disrupting the abnormal electrical pathways in the heart causing arrhythmia. Currently, numerous technological advances in contact-force measurement have gradually increased the radiofrequency ablation success of AFib.
In terms of end-use, the overall cardiovascular devices are segmented into cardiac centers, ambulatory surgical centers, hospitals, and others. In 2020, the hospitals segment held around 55% of the overall market share and is estimated to witness the highest growth over the forecast time period. Presence of highly equipped cardiac facility and investment capability in hospitals will attract larger patient pool, thereby favoring the segmental growth.
From a regional frame of reference, Asia Pacific cardiovascular devices market will witness a respectable CAGR of more than 16.7% over the forecast time period. Some of the key factors such as large baby boomer pool suffering from various CVDs, entry of new market players and expansion of portfolio of existing firms in the region will further contribute towards regional growth.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definitions
- 1.2 Base estimates and working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 LATAM
- 1.2.5 MEA
- 1.3 Forecast calculations
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Cardiovascular devices industry 360 degree synopsis, 2016 - 2027 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Device type trends
- 2.1.3 End-use trends
- 2.1.4 Regional trends
Chapter 3 Cardiovascular Devices Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2016- 2027 (USD Million)
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Increasing number of patients suffering from cardiovascular diseases
- 3.3.1.2 Growing geriatric population contributing to global cardiovascular disease burden
- 3.3.1.3 Increasing government initiatives
- 3.3.1.4 Technological advancements in cardiovascular devices
- 3.3.1.5 Rising demand for minimally invasive procedures
- 3.3.2 Industry pitfalls and challenges
- 3.3.2.1 High risk associated with cardiac procedures
- 3.3.2.2 Stringent regulatory scenario
- 3.4 Growth potential analysis
- 3.4.1 By device type
- 3.4.2 By end-use
- 3.5 COVID-19 impact analysis
- 3.6 Market size by approach, 2016 - 2027 (USD Million)
- 3.6.1 Cardiac ablation devices market
- 3.6.1.1 North America
- 3.6.1.2 Europe
- 3.6.1.3 Asia Pacific
- 3.6.1.4 Latin America
- 3.6.1.5 MEA
- 3.6.2 Left atrial appendage devices market
- 3.6.2.1 North America
- 3.6.2.2 Europe
- 3.6.2.3 Asia Pacific
- 3.6.2.4 Latin America
- 3.6.2.5 MEA
- 3.7 Regulatory landscape
- 3.8 Porter's analysis
- 3.9 Competitive landscape, 2020
- 3.9.1 Company matrix analysis
- 3.10 PESTEL analysis
Chapter 4 Cardiovascular Devices Market, By Device Type
- 4.1 Key segment trends
- 4.2 Cardiac ablation devices
- 4.2.1 Market size, by region, 2016-2027 (USD Million)
- 4.2.2 Radiofrequency ablators
- 4.2.2.1 Market size, by region, 2016-2027 (USD Million)
- 4.2.3 Electric ablators
- 4.2.3.1 Market size, by region, 2016-2027 (USD Million)
- 4.2.4 Cryoablation devices
- 4.2.4.1 Market size, by region, 2016-2027 (USD Million)
- 4.2.5 Ultrasound devices
- 4.2.5.1 Market size, by region, 2016-2027 (USD Million)
- 4.2.6 Others
- 4.2.6.1 Market size, by region, 2016-2027 (USD Million)
- 4.3 Left atrial appendage closure devices
- 4.3.1 Market size, by region, 2016-2027 (USD Million)
- 4.3.2 Endocardial LAA closure devices
- 4.3.2.1 Market size, by region, 2016-2027 (USD Million)
- 4.3.3 Epicardial LAA closure devices
- 4.3.3.1 Market size, by region, 2016-2027 (USD Million)
- 4.4 Endoscopic vessel harvesting devices
- 4.4.1 Market size, by region, 2016-2027 (USD Million)
- 4.4.2 EVH systems
- 4.4.2.1 Market size, by region, 2016-2027 (USD Million)
- 4.4.3 Endoscopes
- 4.4.3.1 Market size, by region, 2016-2027 (USD Million)
- 4.4.4 Accessories
- 4.4.4.1 Market size, by region, 2016-2027 (USD Million)
Chapter 5 Cardiovascular Devices Market, By End-use
- 5.1 Key segment trends
- 5.2 Hospitals
- 5.2.1 Market size, by region, 2016-2027 (USD Million)
- 5.3 Ambulatory surgical centers
- 5.3.1 Market size, by region, 2016-2027 (USD Million)
- 5.4 Cardiac centers
- 5.4.1 Market size, by region, 2016-2027 (USD Million)
- 5.5 Others
- 5.5.1 Market size, by region, 2016-2027 (USD Million)
Chapter 6 Cardiovascular Devices Market, By Region
- 6.1 Key regional trends
- 6.2 North America
- 6.2.1 Market size, by country, 2016 - 2027 (USD Million)
- 6.2.2 Market size, by device type, 2016 - 2027 (USD Million)
- 6.2.2.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.2.2.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.2.2.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.2.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 6.2.4 U.S.
- 6.2.4.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.2.4.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.2.4.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.2.4.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.2.4.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.2.5 Canada
- 6.2.5.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.2.5.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.2.5.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.2.5.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.2.5.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.3 Europe
- 6.3.1 Market size, by country, 2016 - 2027 (USD Million)
- 6.3.2 Market size, by device type, 2016 - 2027 (USD Million)
- 6.3.2.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.3.2.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.3.2.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.3.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 6.3.4 Germany
- 6.3.4.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.3.4.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.3.4.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.3.4.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.3.4.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.3.5 UK
- 6.3.5.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.3.5.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.3.5.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.3.5.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.3.5.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.3.6 France
- 6.3.6.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.3.6.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.3.6.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.3.6.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.3.6.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.3.7 Spain
- 6.3.7.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.3.7.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.3.7.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.3.7.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.3.7.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.3.8 Italy
- 6.3.8.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.3.8.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.3.8.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.3.8.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.3.8.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.4 Asia Pacific
- 6.4.1 Market size, by country, 2016 - 2027 (USD Million)
- 6.4.2 Market size, by device type, 2016 - 2027 (USD Million)
- 6.4.2.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.4.2.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.4.2.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.4.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 6.4.4 China
- 6.4.4.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.4.4.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.4.4.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.4.4.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.4.4.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.4.5 Japan
- 6.4.5.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.4.5.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.4.5.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.4.5.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.4.5.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.4.6 India
- 6.4.6.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.4.6.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.4.6.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.4.6.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.4.6.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.4.7 Australia
- 6.4.7.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.4.7.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.4.7.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.4.7.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.4.7.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.4.8 South Korea
- 6.4.8.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.4.8.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.4.8.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.4.8.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.4.8.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.5 Latin America
- 6.5.1 Market size, by country, 2016 - 2027 (USD Million)
- 6.5.2 Market size, by device type, 2016 - 2027 (USD Million)
- 6.5.2.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.5.2.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.5.2.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 6.5.4 Brazil
- 6.5.4.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.5.4.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.5.4.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.5.4.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.5.4.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.5.5 Mexico
- 6.5.5.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.5.5.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.5.5.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.5.5.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.5.5.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.5.6 Argentina
- 6.5.6.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.5.6.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.5.6.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.5.6.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.5.6.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.6 MEA
- 6.6.1 Market size, by country, 2016 - 2027 (USD Million)
- 6.6.2 Market size, by device type, 2016 - 2027 (USD Million)
- 6.6.2.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.6.2.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.6.2.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 6.6.4 Saudi Arabia
- 6.6.4.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.6.4.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.6.4.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.6.4.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.6.4.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.6.5 South Africa
- 6.6.5.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.6.5.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.6.5.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.6.5.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.6.5.2 Market size, by end-use, 2016 - 2027 (USD million)
- 6.6.6 UAE
- 6.6.6.1 Market size, by device type, 2016 - 2027 (USD Million)
- 6.6.6.1.1 Market size, by cardiac ablation devices, 2016 - 2027 (USD Million)
- 6.6.6.1.2 Market size, by left atrial appendage closure devices, 2016 - 2027 (USD Million)
- 6.6.6.1.3 Market size, by endoscopic vessel harvesting devices, 2016 - 2027 (USD Million)
- 6.6.6.2 Market size, by end-use, 2016 - 2027 (USD million)
Chapter 7 Company Profiles
- 7.1 Competitive dashboard, 2020
- 7.2 Abbott Laboratories
- 7.2.1 Business overview
- 7.2.2 Financial data
- 7.2.3 Product landscape
- 7.2.4 Strategic outlook
- 7.2.5 SWOT analysis
- 7.3 AngioDynamics, Inc
- 7.3.1 Business overview
- 7.3.2 Financial data
- 7.3.3 Product landscape
- 7.3.4 Strategic outlook
- 7.3.5 SWOT analysis
- 7.4 AtriCure, Inc
- 7.4.1 Business overview
- 7.4.2 Financial data
- 7.4.3 Product landscape
- 7.4.4 Strategic outlook
- 7.4.5 SWOT analysis
- 7.5 Biosense Webster (Johnson & Johnson)
- 7.5.1 Business overview
- 7.5.2 Financial data
- 7.5.3 Product landscape
- 7.5.4 Strategic outlook
- 7.5.5 SWOT analysis
- 7.6 Boston Scientific Corporation
- 7.6.1 Business overview
- 7.6.2 Financial data
- 7.6.3 Product landscape
- 7.6.4 Strategic outlook
- 7.6.5 SWOT analysis
- 7.7 Biotronik SE & Co KG
- 7.7.1 Business overview
- 7.7.2 Financial data
- 7.7.3 Product landscape
- 7.7.4 Strategic outlook
- 7.7.5 SWOT analysis
- 7.8 CardioFocus
- 7.8.1 Business overview
- 7.8.2 Financial data
- 7.8.3 Product landscape
- 7.8.4 Strategic outlook
- 7.8.5 SWOT analysis
- 7.9 Getinge AB
- 7.9.1 Business overview
- 7.9.2 Financial data
- 7.9.3 Product landscape
- 7.9.4 Strategic outlook
- 7.9.5 SWOT analysis
- 7.10 Japan Lifeline Co Ltd
- 7.10.1 Business overview
- 7.10.2 Financial data
- 7.10.3 Product landscape
- 7.10.4 Strategic outlook
- 7.10.5 SWOT analysis
- 7.11 KARL STORZ
- 7.11.1 Business overview
- 7.11.2 Financial data
- 7.11.3 Product landscape
- 7.11.4 Strategic outlook
- 7.11.5 SWOT analysis
- 7.12 Lepu Medical Technology(Beijing)Co Ltd
- 7.12.1 Business overview
- 7.12.2 Financial data
- 7.12.3 Product landscape
- 7.12.4 Strategic outlook
- 7.12.5 SWOT analysis
- 7.13 Lifetech Scientific
- 7.13.1 Business overview
- 7.13.2 Financial data
- 7.13.3 Product landscape
- 7.13.4 Strategic outlook
- 7.13.5 SWOT analysis
- 7.14 LivaNova PLC
- 7.14.1 Business overview
- 7.14.2 Financial data
- 7.14.3 Product landscape
- 7.14.4 Strategic outlook
- 7.14.5 SWOT analysis
- 7.15 MicroPort Scientific Corporation
- 7.15.1 Business overview
- 7.15.2 Financial data
- 7.15.3 Product landscape
- 7.15.4 Strategic outlook
- 7.15.5 SWOT analysis
- 7.16 Medical Instruments Spa
- 7.16.1 Business overview
- 7.16.2 Financial data
- 7.16.3 Product landscape
- 7.16.4 Strategic outlook
- 7.16.5 SWOT analysis
- 7.17 Medtronic
- 7.17.1 Business overview
- 7.17.2 Financial data
- 7.17.3 Product landscape
- 7.17.4 Strategic outlook
- 7.17.5 SWOT analysis
- 7.18 Occlutech
- 7.18.1 Business overview
- 7.18.2 Financial data
- 7.18.3 Product landscape
- 7.18.4 Strategic outlook
- 7.18.5 SWOT analysis
- 7.19 Saphena Medical
- 7.19.1 Business overview
- 7.19.2 Financial data
- 7.19.3 Product landscape
- 7.19.4 Strategic outlook
- 7.19.5 SWOT analysis
- 7.20 Stereotaxis, Inc
- 7.20.1 Business overview
- 7.20.2 Financial data
- 7.20.3 Product landscape
- 7.20.4 Strategic outlook
- 7.20.5 SWOT analysis
- 7.21 Terumo Corporation
- 7.21.1 Business overview
- 7.21.2 Financial data
- 7.21.3 Product landscape
- 7.21.4 Strategic outlook
- 7.21.5 SWOT analysis